AIOS

AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving >200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy exists at the intersection of two strong theses: The AI doctor that wins will get to escape velocity using GLP-1s, the fastest growing consumer product in history. The $2T European healthcare market is overlooked by the most talented builders. : We went from $10M to $100M in 6 months serving the UK GLP-1 market. : Over the last 12 months we've grown from 3k to 150k UK active GLP-1 patients. We’ll continue this growth curve to hit $1B ARR. : Blitzscale Europe. We’ll be Europe’s largest GLP-1 provider. : Get regulatory approval across Europe for our Full Autonomous Prescribing (FAP) system. Win contracts at scale with European payers to mass replace human labor. We’ll be the dominant full-stack AI doctor in Europe